Skip to main content

Table 3 Association of HER2 expression with clinicopathological parameters of patients with UBC (n = 103)

From: Expression of human epidermal growth factor receptor 2 in bladder urothelial carcinoma

  Univariate analysis Multivariate analysis
OR IC 95% P-Value OR IC95% P-Value
Age 1.01 0.96–1.06 0.77    
Sex
 Women 1      
 Men 1.29 0.14–11.7 0.82    
Tumor size
 < 3 cm 1    1   
 ≥ 3 cm 2.35 0.6–9.26 0.22 0.73 0.12–4.46 0.74
Papillary architecture
 Absent 1    1   
 Present 0.33 0.1–1.14 0.081 0.93 0.18–4.9 0.94
Carcinoma in situ
 Absent 1    1   
 Present 0.01 0.01-6.4E + 19 0.84 0.73 0.01-6.2E + 17 0.81
Tumor grade
 Low 1    1   
 High 7.5 1.9–29.9 0.004 5.67 1.1–30.2 0.042
Micropapillary differentiation
 Absent 1    1   
 Present 4.04 0.34–48.3 0.27 1.7 0.1–30.4 0.72
T stage
 ≤ pT1 1    1   
 >pT1 5.06 1.4–17.8 0.012 2.58 0.55–12.2 0.29
  1. Italic: Statistically significant at p <0.05
\